Neurorehabilitation News

Therapist-supported internet-based exposure and response therapy led to higher response rates and was cost effective for young persons with Tourette syndrome or chronic tic disorder compared with internet-delivered tic education.

SAN DIEGO — A new neuropsychological test battery may be valuable for assessment of culturally diverse populations if barriers for testing are considered, according to an expert at the Alzheimer’s Association International Conference.

Patients with MS who took diroximel fumarate reported physical benefits, including slowed disease progression and decreased relapses, according to data presented at the Consortium of Multiple Sclerosis Centers annual meeting.

NYU Langone Health has been named the top hospital in the United States for neurology and neurosurgery, according to the latest survey from U.S. News & World Report.

RapidAI has announced FDA clearance for Rapid Hyperdensity, a diagnostic tool that enables physicians to quickly assess the severity of injury in patients with acute conditions, such as traumatic brain injury and brain hemorrhages.

The Kessler Foundation received multiple grants from the New Jersey Health Foundation for research projects that aim to improve cognition and mobility in patients with neurological disabilities, the foundation announced in a press release.

Adherence to a Mediterranean diet was associated with better cognitive performance and decreased learning and memory decline after 7 years among middle-aged and older Hispanic or Latino adults, per a study published in JAMA Network Open.

The FDA has granted approval to Azurity Pharmaceuticals Inc. for its oral adjunctive therapy to treat partial seizures in adolescents and adults aged 16 years and older with epilepsy.

Treatment with ketamine significantly improved seizure occurrence related to refractory status epilepticus in both neonates and children, according to results of a study published in Neurology.

Labcorp Diagnostics announced the launch of the first widely accessible blood test that provides direct evidence of neurodegeneration and neuronal injury.